{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:31:48Z","timestamp":1792758708016,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020884","name":"Agencia Nacional de Investigaci\u00f3n y Desarrollo","doi-asserted-by":"publisher","award":["21170233"],"award-info":[{"award-number":["21170233"]}],"id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"Fondo Nacional de Desarrollo Cient\u00edfico y Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["1210627"],"award-info":[{"award-number":["1210627"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"publisher","award":["SFPI\/2020-00053"],"award-info":[{"award-number":["SFPI\/2020-00053"]}],"id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.bbadis.2022.166525","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T02:22:24Z","timestamp":1660789344000},"page":"166525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Resolvin E1 attenuates doxorubicin-induced cardiac fibroblast senescence: A key role for IL-1\u03b2"],"prefix":"10.1016","volume":"1868","author":[{"given":"Jenaro A.","family":"Espitia-Corredor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licia","family":"Shamoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Olivares-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza","family":"Rimassa-Tar\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mu\u00f1oz-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Espinoza-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos F.","family":"S\u00e1nchez-Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Peir\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"D\u00edaz-Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbadis.2022.166525_bb0005","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/FJC.0b013e31820cda19","article-title":"The cardiac fibroblast: functional and electrophysiological considerations in healthy and diseased hearts","volume":"57","author":"Vasquez","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bbadis.2022.166525_bb0010","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.phrs.2015.07.001","article-title":"Cardiac fibroblasts as sentinel cells in cardiac tissue: receptors, signaling pathways and cellular functions","volume":"101","author":"Diaz-Araya","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"3","key":"10.1016\/j.bbadis.2022.166525_bb0015","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1172\/JCI64098","article-title":"Cellular senescence and the senescent secretory phenotype: therapeutic opportunities","volume":"123","author":"Tchkonia","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bbadis.2022.166525_bb0020","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/emboj.2011.69","article-title":"p38MAPK is a novel DNA damage response-independent regulator of the senescence-associated secretory phenotype","volume":"30","author":"Freund","year":"2011","journal-title":"EMBO J."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166525_bb0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.18632\/aging.100281","article-title":"Cell cycle arrest is not senescence","volume":"3","author":"Blagosklonny","year":"2011","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.bbadis.2022.166525_bb0030","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1038\/s41598-017-02380-1","article-title":"Induction of senescence in primary glioblastoma cells by serum and TGF\u03b2","volume":"7","author":"Kumar","year":"2017","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.bbadis.2022.166525_bb0035","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.3390\/antiox10121924","article-title":"Resolvin D1 suppresses H(2)O(2)-induced senescence in fibroblasts by inducing autophagy through the miR-1299\/ARG2\/ARL1 axis","volume":"10","author":"Kim","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"45","key":"10.1016\/j.bbadis.2022.166525_bb0040","doi-asserted-by":"crossref","first-page":"72443","DOI":"10.18632\/oncotarget.12494","article-title":"A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence","volume":"7","author":"Ghosh","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbadis.2022.166525_bb0045","article-title":"Senescence mechanisms and targets in the heart","author":"Chen","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166525_bb0050","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/FJC.0000000000000878","article-title":"Senolytic agent navitoclax inhibits angiotensin II-induced heart failure in mice","volume":"76","author":"Jia","year":"2020","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166525_bb0055","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1536\/ihj.18-701","article-title":"Activation of DNA damage response and cellular senescence in cardiac fibroblasts limit cardiac fibrosis after myocardial infarction","volume":"60","author":"Shibamoto","year":"2019","journal-title":"Int. Heart J."},{"issue":"17","key":"10.1016\/j.bbadis.2022.166525_bb0060","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.jacc.2016.02.048","article-title":"Fibroblast senescence as a therapeutic target of myocardial fibrosis: beyond spironolactone?","volume":"67","author":"Condorelli","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"17","key":"10.1016\/j.bbadis.2022.166525_bb0065","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.jacc.2016.02.047","article-title":"Essential role for premature senescence of myofibroblasts in myocardial fibrosis","volume":"67","author":"Meyer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bbadis.2022.166525_bb0070","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000265166","article-title":"Doxorubicin cardiomyopathy","volume":"115","author":"Chatterjee","year":"2010","journal-title":"Cardiology"},{"key":"10.1016\/j.bbadis.2022.166525_bb0075","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11357-018-0025-z","article-title":"Accelerated vascular aging and persistent cognitive impairment in older female breast cancer survivors","volume":"40","author":"Carlson","year":"2018","journal-title":"GeroScience"},{"key":"10.1016\/j.bbadis.2022.166525_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/aac2.12033","article-title":"Anthracycline chemotherapy-mediated vascular dysfunction as a model of accelerated vascular aging","volume":"2","author":"Clayton","year":"2021","journal-title":"Aging Cancer"},{"issue":"9","key":"10.1016\/j.bbadis.2022.166525_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221940","article-title":"Doxorubicin induces trans-differentiation and MMP1 expression in cardiac fibroblasts via cell death-independent pathways","volume":"14","author":"Narikawa","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bbadis.2022.166525_bb0090","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12012-020-09576-4","article-title":"Involvement of ROS\/NLRP3 inflammasome signaling pathway in doxorubicin-induced cardiotoxicity","volume":"20","author":"Wei","year":"2020","journal-title":"Cardiovasc. Toxicol."},{"issue":"9","key":"10.1016\/j.bbadis.2022.166525_bb0095","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.4049\/jimmunol.1102048","article-title":"IL-1alpha and IL-1\u03b2 recruit different myeloid cells and promote different stages of sterile inflammation","volume":"187","author":"Rider","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2022.166525_bb0100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molimm.2016.05.001","article-title":"Expression and function of toll-like receptor 4 and inflammasomes in cardiac fibroblasts and myofibroblasts: IL-1\u03b2 synthesis, secretion, and degradation","volume":"74","author":"Boza","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.bbadis.2022.166525_bb0105","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cellsig.2011.12.006","article-title":"Emerging role of NF-kappaB signaling in the induction of senescence-associated secretory phenotype (SASP)","volume":"24","author":"Salminen","year":"2012","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbadis.2022.166525_bb0110","doi-asserted-by":"crossref","first-page":"931","DOI":"10.18632\/aging.100702","article-title":"Loss of Nfkb1 leads to early onset aging","volume":"6","author":"Bernal","year":"2014","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"10.1016\/j.bbadis.2022.166525_bb0115","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.4049\/jimmunol.180.5.3512","article-title":"Resolvin E1 metabolome in local inactivation during inflammation-resolution","volume":"180","author":"Hong","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2022.166525_bb0120","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2022.166525_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11033-020-06133-8","article-title":"Resolvin D1 and E1 promote resolution of inflammation in rat cardiac fibroblast in vitro","volume":"48","author":"Salas-Hernandez","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bbadis.2022.166525_bb0130","series-title":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals., Guide for the Care and Use of Laboratory Animals., Washington (DC), USA: 8th edition","year":"2011"},{"issue":"351","key":"10.1016\/j.bbadis.2022.166525_bb0135","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.taap.2018.05.011","article-title":"Expression and function of TLR4- induced B1R bradykinin receptor on cardiac fibroblasts","volume":"15","author":"Mu\u00f1oz-Rodr\u00edguez","year":"2018","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbadis.2022.166525_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12913","article-title":"The angiotensin-(1\u20137)\/Mas receptor axis protects from endothelial cell senescence via klotho and Nrf2 activation","volume":"18","author":"Romero","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbadis.2022.166525_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101150","article-title":"Mechanosensing dysregulation in the fibroblast: a hallmark of the aging heart","volume":"63","author":"Angelini","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbadis.2022.166525_bb0150","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Octavia","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2022.166525_bb0155","first-page":"756","article-title":"A concise description of cardio- protective strategies in doxorubicin-induced cardiotoxicity","volume":"87","author":"Ludke","year":"2009","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166525_bb0160","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.yexcr.2019.05.020","article-title":"The paracrine effects of fibroblasts on doxorubicin-treated breast cancer cells","volume":"381","author":"Fourie","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbadis.2022.166525_bb0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.phrs.2017.03.016","article-title":"Doxorubicin targets multiple players: a new view of an old problem","volume":"127","author":"Cappetta","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.bbadis.2022.166525_bb0170","doi-asserted-by":"crossref","first-page":"13788","DOI":"10.18632\/aging.202972","article-title":"Redd1 knockdown prevents doxorubicin-induced cardiac senescence","volume":"13","author":"Huang","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"10.1016\/j.bbadis.2022.166525_bb0175","first-page":"3417","article-title":"Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols","volume":"43","author":"Greene","year":"1983","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bbadis.2022.166525_bb0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11897-021-00519-w","article-title":"The interplay between autophagy and senescence in anthracycline cardiotoxicity","volume":"18","author":"Russo","year":"2021","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.bbadis.2022.166525_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2016.05.011","article-title":"Senescent endothelial cells: potential modulators of immunosenescence and ageing","volume":"29","author":"Pantsulaia","year":"2016","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bbadis.2022.166525_bb0190","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1474-9726.2007.00358.x","article-title":"Induction of premature senescence in cardiomyocytes by doxorubicin as a novel mechanism of myocardial damage","volume":"7","author":"Maejima","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.bbadis.2022.166525_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015583","article-title":"p38 MAPK and JNK antagonistically control senescence and cytoplasmic p16INK4A expression in doxorubicin-treated endothelial progenitor cells","volume":"5","author":"Spallarossa","year":"2010","journal-title":"PLOS ONE"},{"key":"10.1016\/j.bbadis.2022.166525_bb0200","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","article-title":"Hallmarks of cellular senescence","volume":"28","author":"Hernandez-Segura","year":"2018","journal-title":"Trends Cell Biol."},{"issue":"22","key":"10.1016\/j.bbadis.2022.166525_bb0205","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-15-3034","article-title":"Doxorubicin-induced systemic inflammation is driven by upregulation of toll-like receptor TLR4 and endotoxin leakage","volume":"76","author":"Wang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbadis.2022.166525_bb0210","article-title":"Cardiac inflammation and fibrosis following chemo\/radiation therapy: mechanisms and therapeutic agents","author":"Yang","year":"2021","journal-title":"Inflammopharmacology."},{"key":"10.1016\/j.bbadis.2022.166525_bb0215","article-title":"The role of cellular senescence in cardiac disease: basic biology and clinical relevance","author":"Mehdizadeh","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"712","key":"10.1016\/j.bbadis.2022.166525_bb0220","article-title":"Nicotinamide mononucleotide attenuates doxorubicin-induced cardiotoxicity by reducing oxidative stress, inflammation and apoptosis in rats","volume":"15","author":"Wan","year":"2021","journal-title":"Arch. Biochem. Biophys."},{"issue":"2","key":"10.1016\/j.bbadis.2022.166525_bb0225","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.bbalip.2016.11.003","article-title":"Palmitate promotes inflammatory responses and cellular senescence in cardiac fibroblasts","volume":"1862","author":"Sokolova","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"12","key":"10.1016\/j.bbadis.2022.166525_bb0230","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.4161\/cbt.11.12.15540","article-title":"Doxorubicin and daunorubicin induce processing and release of interleukin-1\u03b2 through activation of the NLRP3 inflammasome","volume":"11","author":"Sauter","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"6","key":"10.1016\/j.bbadis.2022.166525_bb0235","doi-asserted-by":"crossref","first-page":"26489","DOI":"10.1038\/srep26489","article-title":"NLRP3 deficiency reduces macrophage Interleukin-10 production and enhances the susceptibility to doxorubicin-induced cardiotoxicity","volume":"26","author":"Kobayashi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2022.166525_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115078","article-title":"Resolvin e1 attenuates doxorubicin-induced endothelial senescence by modulating NLRP3 inflammasome activation","author":"Shamoon","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"40","key":"10.1016\/j.bbadis.2022.166525_bb0245","doi-asserted-by":"crossref","first-page":"25796","DOI":"10.1074\/jbc.273.40.25796","article-title":"Cardiac fibroblasts arrest at the G1\/S restriction point in response to interleukin (IL)-1\u03b2. Evidence for IL-1\u03b2-induced hypophosphorylation of the retinoblastoma protein","volume":"273","author":"Koudssi","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"101","key":"10.1016\/j.bbadis.2022.166525_bb0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.yjmcc.2016.10.014","article-title":"Cardiac fibroblast cytokine profiles induced by proinflammatory or profibrotic stimuli promote monocyte recruitment and modulate macrophage M1\/M2 balance in vitro","volume":"31","author":"Humeres","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bbadis.2022.166525_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114188","article-title":"Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT\/mTOR signaling","volume":"180","author":"Zhang","year":"2020","journal-title":"Biochem. Pharmacol."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392200196X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092544392200196X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:15:14Z","timestamp":1760418914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092544392200196X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S092544392200196X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166525","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resolvin E1 attenuates doxorubicin-induced cardiac fibroblast senescence: A key role for IL-1\u03b2","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2022.166525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"166525"}}